Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
Abstract Introduction Cancer testis (CT) antigens are attractive targets for cancer immunotherapy because of their expression restriction and immunogenicity. The acrosin binding protein (ACRBP) is a member of CT antigens. This study aimed to evaluate ACRBP expression and immunogenicity in ovarian ca...
Saved in:
Main Authors: | Lina Lin, Weixia Nong, Bin Luo, Yingying Ge, Xia Zeng, Feng Li, Rong Fan, Qingmei Zhang, Xiaoxun Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.534 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01) -
EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
by: D. S. Kutilin, et al.
Published: (2019-07-01) -
ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01) -
Cancer-testis antigen MAGE-C1/ CT7 in multiple myeloma: literature review
by: E. A. Makunina
Published: (2020-12-01) -
An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer
by: Kenji Murata, et al.
Published: (2025-12-01)